Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$304.11 - $351.99 $2.22 Million - $2.57 Million
-7,306 Reduced 85.31%
1,258 $435,000
Q4 2023

Feb 01, 2024

BUY
$269.37 - $365.04 $1.87 Million - $2.54 Million
6,953 Added 431.6%
8,564 $2.77 Million
Q3 2023

Nov 02, 2023

SELL
$350.25 - $422.63 $1.91 Million - $2.31 Million
-5,463 Reduced 77.23%
1,611 $577,000
Q2 2023

Jul 31, 2023

BUY
$359.49 - $486.4 $2.39 Million - $3.24 Million
6,656 Added 1592.34%
7,074 $2.68 Million
Q1 2023

Jun 27, 2023

BUY
$418.69 - $503.0 $175,012 - $210,254
418 New
418 $200,000
Q3 2022

Nov 03, 2022

BUY
$412.59 - $563.26 $3.71 Million - $5.07 Million
9,003 New
9,003 $3.76 Million
Q2 2022

Aug 08, 2022

SELL
$463.67 - $597.16 $4.33 Million - $5.58 Million
-9,349 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$524.57 - $735.42 $4.9 Million - $6.88 Million
9,349 New
9,349 $5.27 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.1B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.